Ampicillin

CLINICAL USE

Antibacterial agent

DOSE IN NORMAL RENAL FUNCTION

Oral: 250 mg – 1 g every 6 hours
IM/IV: 500 mg – 2 g every 4–6 hours

PHARMACOKINETICS

Molecular weight :
349.4

%Protein binding :
20

%Excreted unchanged in urine :
Oral: 20–60;
Parenteral: 60–80

Volume of distribution (L/kg) :
0.17–0.31

half-life – normal/ESRD (hrs) :
1–1.5/7–20

DOSE IN RENAL IMPAIRMENT

GFR (mL/MIN)

20 to 50 : Dose as in normal renal function

10 to 20 : 250 mg – 2 g every 6 hours

<10 :
250 mg –1 g every 6 hours

DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES

CAPD :
Not dialysed. Dose as in
GFR <10 mL/min

HD :
Dialysed. Dose as in GFR

<10 : mL/
min

HDF/high flux :
Dialysed. Dose as in GFR

<10 : mL/
min

CAV/VVHD :
Dialysed. Dose as in GFR=10–
20 mL/min

IMPORTANT DRUG INTERACTIONS

Potentially hazardous interactions with other drugs
Ciclosporin: may increase ciclosporin

levels
Reduces excretion of methotrexate

(increased risk of toxicity)

ADMINISTRATION

Reconstition

Use water for injection: 5 mL for each

250 mg (1.5 mL for 250 mg or 500 mg for
IM administration)

Route

Oral, IV, IM

Rate of Administration

Slow IV bolus over 3–4 minutes. Doses

greater than 500 mg should be given by
infusion

Comments

Can be diluted in glucose 5% or sodium

chloride 0.9%

OTHER INFORMATION

Rashes more common in patients withrenal impairment

Can cause nephrotoxicity if dose notreduced in renal impairment

Sodium content of injection1.47 mmol/500 mg vial

Ampicillin may be used in peritonealdialysis fluids for treatment of peritonitis
Do not mix with aminoglycosides

Tags: post-by-auto-php